Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Analytical Strategies for Cell and Gene Therapy Development

July 01, 2021

Developing bioassay methods requires a new approach for cell and gene therapy drug development.

Yposkesi’s Bioproduction Project Selected for French Government Investment

June 30, 2021

CDMO Yposkesi will increase its current gene therapy vector capacity through French government’s “Plan de Relance” scheme.

Lonza and CellPoint Collaborate to Develop T-cell Based Therapies

June 24, 2021

The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.

SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate

June 24, 2021

The companies have entered into an agreement to develop processes for a novel immunotherapy protein.

Centrient Pharmaceuticals Adds API Capacity

June 23, 2021

Centrient started production at its new statins API manufacturing unit in Toansa, India.

Vectura Signs Agreement with Incannex to Advance TBI Treatment

June 22, 2021

Vectura has signed an agreement with Incannex Healthcare for the pre-clinical development of IHL-216A, an inhaled drug product for the treatment of traumatic brain injury.

Outlining the Key Steps to Method Development

June 22, 2021

Thought and foresight into method development stages can ensure costly errors and delays are avoided later on.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

June 08, 2021

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

AGC Biologics to Supply More Plasmid DNA for Pfizer-BioNTech COVID-19 Vaccine

June 08, 2021

AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.

MedPharm Opens Manufacturing Facility for Topical and Transdermal Drug Products

June 04, 2021

MedPharm’s new facility for process development and small-scale manufacturing is in North Carolina, near its existing R&D center.